Belgomed SRL
Belgomed reported total assets of 184,456 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Belgomed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belgomed's annual accounts
| 2025 | |
|---|---|
| Net result | 44,149 € |
| Equity | 74,149 € |
| Cash | 68,143 € |
| Total assets | 184,456 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
Belgomed's financial analysis
- Solvency40.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belgomed
Belgomed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.733.943
- VAT number
- BE1012733943
- Peppol
- Registered · 0208:1012733943 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Aug 2024
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Belgomed (SRL) has been based in Hasselt since 2024, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 44,149 € and equity of 74,149 €; its revenue is not published. Its solvency stands at 40.2%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Belgomed
Companies in the same business, of comparable size and area, outside its group.
- Departement Central de Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Uniphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet 476,976 €
- Barette Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 615,019 €
- Guerbet Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €3.45m
- Vétoquinol Wholesale of pharmaceutical and medical goods Niel · balance sheet €5.15m
- Zambon Wholesale of pharmaceutical and medical goods Jette · balance sheet €7.67m
- Ultimedi Wholesale of pharmaceutical and medical goods Wingene · balance sheet €6.99m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
Frequently asked questions about Belgomed
What is the revenue of Belgomed?
Belgomed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belgomed?
In Belgium, the VAT number is the company number prefixed with BE: BE1012733943 for Belgomed, if the company is VAT-registered. Its company number (CBE) is 1012.733.943.
Where is the registered office of Belgomed?
According to the CBE register, the registered office of Belgomed is in 3500 Hasselt.
What is the equity of Belgomed?
At the close of the 2025 financial year, the equity of Belgomed amounts to 74,149 €, a solvency of 40.2% of total assets.
Who manages Belgomed?
The register lists 2 active mandates at Belgomed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belgomed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →